Category: Uncategorized

Author – Emma Boxall, Marketing & Innovations Manager, Alpha Laboratories Ltd. The impact of the Faecal Immunochemical Test (FIT) on the colorectal cancer referral pathway is well documented. Having a quick and easy-to-use test, that can be directly loaded onto the automated testing platform in the laboratory makes it an ideal solution for triaging the

The new test, called FIT – faecal immunochemical test – was introduced in 2017 and uptake has risen from 55.4% to 63.9%, the first time national uptake has been higher than the standard of 60%. “This report is good news in that we’re seeing a significant rise in screening uptake in the first year since

Bowel cancer testing could indicate whether people are at risk of other health problems, a study of patients in Tayside has suggested. It found when blood is detected in a person’s stool they are at an increased risk of death from other diseases. Having a positive result was significantly associated with increased risk of dying

Get Your Copy of the New Issue of Focus on FIT. Read about the latest clinical thinking on the adoption of FIT for symptomatic testing and how it fits into the primary and secondary care patient pathways for colorectal disease. Plus get updates on current FIT studies that are gathering evidence for the benefits of

A news article by the BBC on the pilot of ‘one-stop shops’ for cancer diagnosis in patients with unclear symptoms. Cally Palmer, national director for Cancer at NHS England, says the new centres could play a key role in improving diagnosis and treatment. “Early diagnosis is crucial to saving lives and providing peace of mind